MedTrace Logo

Program for the Identification of "Actionable" Atrial Fibrillation in the Family Practice Setting

NCT02262351 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2174

Last updated 2018-10-09

No results posted yet for this study

Summary

Atrial fibrillation (AF) is a major risk factor for stroke. The identification and treatment of AF is one of the best way to prevent stroke. The problem is that because AF may cause minimal symptoms, it often goes undetected before a patient suffers a stroke. Also, it is known that as many as half of all patients with known AF may not be receiving appropriate anticoagulation for their condition. New technologies are making it possible to improve AF detection. Subjects in this study will be screened for AF using three simple methods: a 30-second pulse check, a hand-held single-lead electrocardiogram (ECG) device and a blood pressure monitor with built-in AF screening capabilities. If more patients with AF can be detected, more patients will be able to receive guideline-recommended anticoagulant therapy, and more strokes, deaths, disability, and dementia will be prevented.

Conditions

Interventions

OTHER

30 Second Pulse Check

To detect atrial fibrillation

DEVICE

Watch BP Home A

Blood pressure device that detects atrial fibrillation

DEVICE

HeartCheck Hand-held ECG device

To detect atrial fibrillation

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • F. Russell Quinn, MRCP PhD · University of Calgary

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-10-15
Completion
2016-12-02

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02262351 on ClinicalTrials.gov